COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT04205409
Brief Title: Nivolumab for Relapsed or Refractory Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies

First Submitted : December 17, 2019
First Submitted that Met QC Criteria : December 17, 2019
First Posted : December 19, 2019

Last Update Submitted that Met QC Criteria : May 4, 2020
Last Update Posted : May 6, 2020